Precision medicine testing in ovarian cancer: The growing inequity between patients with commercial vs medicaid insurance

This publication has 19 references indexed in Scilit:

• Recent Patterns in Genetic Testing for Breast and Ovarian Cancer Risk in the U.S.
  American Journal of Preventive Medicine, 2017
• A state‐wide initiative to promote genetic testing in an underserved population
  Cancer Medicine, 2017
• Racial disparities in BRCA testing and cancer risk management across a population‐based sample of young breast cancer survivors
  Cancer, 2017
• Health Care Segregation, Physician Recommendation, and Racial Disparities inBRCA1/2Testing Among Women With Breast Cancer
  Journal of Clinical Oncology, 2016
• Underuse of BRCA testing in patients with breast and ovarian cancer
  American Journal of Obstetrics and Gynecology, 2016
• Experiences of Cervical Cancer Survivors in Rural Eastern North Carolina: a Qualitative Assessment
  Journal of Cancer Education, 2015
• Prevention for those who can pay: insurance reimbursement of genetic-based preventive interventions in the liminal state between health and disease
  Journal of Law and the Biosciences, 2015
• Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions
  Gynecologic Oncology, 2015
• First FDA Authorization for Next-Generation Sequencer
  New England Journal of Medicine, 2013
• Barriers and facilitators to BRCA genetic counseling among at‐risk Latinas in New York City
  Psycho-Oncology, 2012